# Elevance Health Q3 2026 Earnings Beat

> Elevance Health tops Q3 2026 earnings estimates with $6.99 EPS, raising full-year baseline to $26.75.
- Title: Elevance Health Q3 2026 Earnings Beat | Shortify
- Summary: Elevance Health tops Q3 2026 earnings estimates with $6.99 EPS, raising full-year baseline to $26.75. Elevance Health reported Q3 2026 adjusted EPS of $6.99…
- Keywords: elevance health, elv, q3 2026, eps, revenue, net income, carelonrx, carelon services, health benefits, Elevance, Health, 2026
- Source: Alphastreet - Earnings Decoded. Market Intelligence Delivered — https://news.alphastreet.com/elevance-health-q3-2026-6-99-eps-tops-estimates-deep-dive
- Author: AlphaStreet Newsdesk
- Published: 2026-10-21T19:55:41+00:00
- Read time: 1 min
- Topics: elevance health, elv, q3 2026, eps, revenue, net income, carelonrx, carelon services, health benefits
## Q3 2026 Earnings Beat
Elevance Health delivered adjusted EPS of $6.99 against a consensus estimate of $4.73.
## EPS Growth and Margin Expansion
The company reported 16% year-over-year EPS growth to $6.99 with 2.7% net margin.
## Revenue Stagnation
Q3 revenue increased 0.7% to $50.44 billion from $50.71 billion in Q3 2025.
## Segment Performance
Health Benefits generated $43.36 billion with 2.6% growth, CarelonRx $11.60 billion with 5.5% growth.
## Management Guidance
Management raised full-year earnings baseline by $0.75 to at least $26.75 and projects 12% eps growth in 2027.

> our earnings baseline increases by $0.75 to at least $26.75, reflecting third quarter operating outperformance and an improved full-year outlook for individual ACA
## Market Reaction
Stock rose 2.3% to $440.18 despite the earnings beat.
## What to Watch
Q4 results will test if raised baseline is conservative and membership trends impact revenue growth.
## Key takeaway

Elevance Health reported Q3 2026 adjusted EPS of $6.99, beating estimates by 47.8% and raising full-year earnings baseline to $26.75.